Clinical Spectrum Associated with Wolfram Syndrome Type 1 and Type 2: A Review on Genotype-Phenotype Correlations
- PMID: 33946243
- PMCID: PMC8124476
- DOI: 10.3390/ijerph18094796
Clinical Spectrum Associated with Wolfram Syndrome Type 1 and Type 2: A Review on Genotype-Phenotype Correlations
Abstract
Wolfram syndrome is a rare neurodegenerative disorder that is typically characterized by diabetes mellitus and optic atrophy. Other common features are diabetes insipidus and hearing loss, but additional less-frequent findings may also be present. The phenotype spectrum is quite wide, and penetrance may be incomplete. The syndrome is progressive, and thus, the clinical picture may change during follow-up. Currently, two different subtypes of this syndrome have been described, and they are associated with two different disease-genes, wolframin (WFS1) and CISD2. These genes encode a transmembrane protein and an endoplasmic reticulum intermembrane protein, respectively. These genes are detected in different organs and account for the pleiotropic features of this syndrome. In this review, we describe the phenotypes of both syndromes and discuss the most pertinent literature about the genotype-phenotype correlation. The clinical presentation of Wolfram syndrome type 1 suggests that the pathogenic variant does not predict the phenotype. There are few papers on Wolfram syndrome type 2 and, thus, predicting the phenotype on the basis of genotype is not yet supported. We also discuss the most pertinent approach to gene analysis.
Keywords: CISD2; ERIS; Wolfram syndrome; diabetes insipidus; diabetes mellitus; genotype-phenotype correlation; molecular genetics; optic atrophy; sensorineural hearing loss; wolframin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Wolfram D.J., Wagener H.P. Diabetes mellitus and simple optic atrophy among siblings: Report of four cases. Mayo. Clinproc. 1938;13:715–718.
-
- Rose F.C., Fraser G.R., Friedmann A.I., Kohner E.M. The association of juvenile diabetes mellitus and optic atrophy: Clinical and genetical aspects. Quart. J. Med. 1966;35:385–405. - PubMed
-
- Inoue H., Tanizawa Y., Wasson J., Behn P., Kalidas K., Bernal-Mizrachi E., Mueckler M., Marshall H., Donis-Keller H., Crock P., et al. A gene encoding a trans membrane protein is mutated in patients with diabetes mellitus and optic atrophy. Nat. Genet. 1998;20:143–148. doi: 10.1038/2441. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
